Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-19-044336

Options or other derivatives

  • VP, Finance and Administration acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MORNEAU MICHAEL VP, Finance and Administration 2019-07-31 Grant or award · Stock Option (Right to Buy) +7,500 7,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…